Crinetics Pharmaceuticals CRNX
NASDAQ CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Operating Margin Growth (3y) (2021 - 2026)

Analysis

Crinetics Pharmaceuticals (CRNX) Operating Margin Growth (3y) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -204.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 7,045.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -1,934.00
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 7,261.00
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 9,003.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - -2,649.00
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 30,461.00
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn 483,652.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 483,652.00
Mar 31, 2026 48,310.00
Dec 31, 2025 453,792.00
Sep 30, 2025 -9.02 Mn
Jun 30, 2025 -271,775.00
Mar 31, 2025 -2.98 Mn
Mar 31, 2023 2.33 Mn
Dec 31, 2022 -196,791.00
Sep 30, 2022 -647,213.00
Mar 31, 2022 165,640.00
Dec 31, 2021 -165,775.00